Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

The effect of sitagliptin on cardiovascular risk profile in Korean patients with type 2 diabetes mellitus: a retrospective cohort study.

Shin S, Kim H.

Ther Clin Risk Manag. 2016 Mar 15;12:435-44. doi: 10.2147/TCRM.S105285. eCollection 2016.

2.

Targeting AMPK signaling in combating ovarian cancers: opportunities and challenges.

Yung MM, Ngan HY, Chan DW.

Acta Biochim Biophys Sin (Shanghai). 2016 Apr;48(4):301-17. doi: 10.1093/abbs/gmv128. Epub 2016 Jan 12. Review.

PMID:
26764240
3.

The effect of metformin on cardiovascular risk profile in patients without diabetes presenting with acute myocardial infarction: data from the Glycometabolic Intervention as adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) trial.

Lexis CP, van der Horst-Schrivers AN, Lipsic E, Valente MA, Muller Kobold AC, de Boer RA, van Veldhuisen DJ, van der Harst P, van der Horst IC.

BMJ Open Diabetes Res Care. 2015 Dec 11;3(1):e000090. doi: 10.1136/bmjdrc-2015-000090. eCollection 2015.

4.

Cymene and Metformin treatment effect on biochemical parameters of male NMRI mice fed with high fat diet.

Lotfi P, Yaghmaei P, Ebrahim-Habibi A.

J Diabetes Metab Disord. 2015 Jun 24;14:52. doi: 10.1186/s40200-015-0182-x. eCollection 2015.

5.
6.

Treatment for overweight and obesity in adult populations: a systematic review and meta-analysis.

Peirson L, Douketis J, Ciliska D, Fitzpatrick-Lewis D, Ali MU, Raina P.

CMAJ Open. 2014 Oct 1;2(4):E306-17. doi: 10.9778/cmajo.20140012. eCollection 2014 Oct.

7.

Effects of metformin on energy intake and satiety in obese children.

Adeyemo MA, McDuffie JR, Kozlosky M, Krakoff J, Calis KA, Brady SM, Yanovski JA.

Diabetes Obes Metab. 2015 Apr;17(4):363-70. doi: 10.1111/dom.12426. Epub 2015 Jan 11.

8.

MARCH2: comparative assessment of therapeutic effects of acarbose and metformin in newly diagnosed type 2 diabetes patients.

Wang G, Liu J, Yang N, Gao X, Fan H, Xu Y, Yang W.

PLoS One. 2014 Aug 22;9(8):e105698. doi: 10.1371/journal.pone.0105698. eCollection 2014.

9.

Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study.

Diabetes Prevention Program Research Group.

Diabetes Care. 2012 Apr;35(4):731-7. doi: 10.2337/dc11-1299.

10.

Tackling obesity: new therapeutic agents for assisted weight loss.

Karam J, McFarlane S.

Diabetes Metab Syndr Obes. 2010 Apr 26;3:95-112.

11.

Present and future: pharmacologic treatment of obesity.

Glandt M, Raz I.

J Obes. 2011;2011:636181. doi: 10.1155/2011/636181. Epub 2011 Feb 8.

12.

Effects of metformin on body weight and body composition in obese insulin-resistant children: a randomized clinical trial.

Yanovski JA, Krakoff J, Salaita CG, McDuffie JR, Kozlosky M, Sebring NG, Reynolds JC, Brady SM, Calis KA.

Diabetes. 2011 Feb;60(2):477-85. doi: 10.2337/db10-1185. Epub 2011 Jan 12.

13.

Clinical evaluation of Dyslipidemia among type II diabetic patients at Public hospital Penang, Malaysia.

Zaki NF, Sulaiman AS, Gillani WS.

Int Arch Med. 2010 Nov 24;3:34. doi: 10.1186/1755-7682-3-34.

14.

Combined pharmacologic/nonpharmacologic intervention in individuals at high risk of developing type 2 diabetes: pro pharmacologic therapy.

Garber AJ.

Diabetes Care. 2009 Nov;32 Suppl 2:S184-8. doi: 10.2337/dc09-S307. Review. No abstract available.

15.

Industry funding and the reporting quality of large long-term weight loss trials.

Thomas O, Thabane L, Douketis J, Chu R, Westfall AO, Allison DB.

Int J Obes (Lond). 2008 Oct;32(10):1531-6. doi: 10.1038/ijo.2008.137. Epub 2008 Aug 19. Review.

16.

Should metformin be prescribed to overweight adolescents in whom dietary/behavioural modifications have not helped?

Webb E, Viner R.

Arch Dis Child. 2006 Sep;91(9):793-4. Review. No abstract available.

17.

Metformin as treatment for overweight and obese adults: a systematic review.

Levri KM, Slaymaker E, Last A, Yeh J, Ference J, D'Amico F, Wilson SA.

Ann Fam Med. 2005 Sep-Oct;3(5):457-61.

18.
19.
20.

Modern pharmacotherapies for type 2 diabetes mellitus.

Hsia SH.

J Natl Med Assoc. 2001 Sep;93(9):335-48; quiz 348-9. Review.

Items per page

Supplemental Content

Write to the Help Desk